Ankur Drugs & Pharma Financials
NSE: ANKURDRUGS | BSE: 531683
₹3.65
₹-0.15
(-3.95%)
As on 10-Sep-2013IST
Market cap
₹8 Cr
Revenue (TTM)
₹143 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
142.84
|
151.49
|
824.85
|
1,067.41
|
965.32
|
673.50
|
|
|
|
|
|
|
Total Income
|
150.07
|
169.03
|
825.78
|
1,086.04
|
968.26
|
675.00
|
|
|
|
|
|
|
Total Expenditure
|
209.33
|
184.23
|
690.95
|
858.65
|
834.57
|
566.65
|
|
|
|
|
|
|
EBITDA
|
-66.49
|
-32.74
|
133.90
|
208.76
|
130.75
|
106.85
|
|
|
|
|
|
|
Depreciation
|
66.21
|
61.19
|
60.80
|
26.64
|
20.67
|
8.40
|
|
|
|
|
|
|
EBIT
|
-132.70
|
-93.94
|
73.10
|
182.12
|
110.08
|
98.44
|
|
|
|
|
|
|
Interest
|
67.24
|
75.71
|
120.80
|
80.75
|
54.10
|
24.93
|
|
|
|
|
|
|
Other Income
|
7.23
|
17.54
|
0.93
|
18.63
|
2.94
|
1.51
|
|
|
|
|
|
|
Exceptional Items
|
--
|
-136.37
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
-216.08
|
-288.47
|
-46.77
|
120.00
|
58.92
|
75.02
|
|
|
|
|
|
|
Provision for Tax
|
--
|
19.02
|
22.04
|
33.82
|
21.79
|
11.51
|
|
|
|
|
|
|
Profit after Tax
|
-247.35
|
-307.49
|
-68.81
|
86.18
|
37.13
|
63.50
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
151.36
|
238.31
|
288.47
|
357.28
|
271.65
|
219.46
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
661.34
|
671.39
|
535.41
|
986.69
|
768.97
|
628.01
|
|
|
|
|
|
|
Current Liabilities
|
684.14
|
618.95
|
955.59
|
529.40
|
93.92
|
52.45
|
|
|
|
|
|
|
Total Liabilities
|
1,496.83
|
1,528.65
|
1,779.48
|
1,873.37
|
1,134.53
|
899.92
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,394.22
|
1,426.91
|
1,506.43
|
1,490.65
|
616.00
|
540.88
|
|
|
|
|
|
|
Current Assets
|
65.68
|
63.05
|
229.52
|
342.56
|
518.28
|
358.52
|
|
|
|
|
|
|
Total Assets
|
1,496.83
|
1,528.65
|
1,779.48
|
1,873.37
|
1,134.53
|
899.92
|
|
|
|
|
|
|
Total Debt*
|
--
|
988.24
|
1,221.58
|
950.41
|
744.70
|
618.14
|
|
|
|
|
|
|
Net Current Assets
|
-618.46
|
-555.90
|
-726.07
|
-186.84
|
424.36
|
306.07
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
12.89
|
6.32
|
32.37
|
40.19
|
25.80
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
3.20
|
-40.54
|
843.72
|
41.87
|
21.50
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
23.96
|
-91.53
|
-938.33
|
-94.27
|
-190.75
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-26.92
|
130.15
|
88.21
|
9.18
|
225.75
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
0.25
|
-1.92
|
-6.41
|
-43.22
|
56.50
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-127.89
|
-158.98
|
-35.58
|
44.56
|
19.94
|
50.00
|
|
|
|
|
|
|
Cash EPS (₹)
|
--
|
-127.34
|
-4.14
|
58.33
|
31.05
|
56.62
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
--
|
-29.84
|
126.64
|
163.96
|
140.40
|
165.52
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
2.25
|
2.25
|
2.25
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
1.65
|
-20.96
|
436.22
|
22.49
|
16.93
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-114.90
|
-139.00
|
-31.50
|
-63.22
|
-131.02
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-16.03
|
5.42
|
17.58
|
12.20
|
15.36
|
|
|
|
|
|
|
ROE (%)
|
-100.00
|
-328.47
|
-24.48
|
29.79
|
15.75
|
40.33
|
|
|
|
|
|
|
ROA (%)
|
-15.28
|
-18.59
|
-3.77
|
5.73
|
3.65
|
9.04
|
|
|
|
|
|
|
EBIT Margin (%)
|
-92.91
|
-62.01
|
8.86
|
17.06
|
11.40
|
14.62
|
|
|
|
|
|
|
Net Margin (%)
|
-164.83
|
-181.91
|
-8.33
|
7.94
|
3.83
|
9.41
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
-161.65
|
-0.97
|
10.54
|
5.96
|
10.64
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-39.52
|
-81.63
|
-22.72
|
10.58
|
43.33
|
80.45
|
|
|
|
|
|
|
EBIT Growth (%)
|
-27.46
|
-228.50
|
-59.86
|
65.43
|
11.82
|
89.47
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-35.85
|
-346.89
|
-179.84
|
132.12
|
-41.54
|
93.99
|
|
|
|
|
|
|
EPS Growth (%)
|
-35.33
|
-346.89
|
-179.84
|
123.40
|
-60.11
|
61.22
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
-123.56
|
-22.76
|
21.33
|
24.33
|
100.77
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
4.54
|
3.46
|
3.62
|
|
|
|
|
|
|
Price / Book Value
|
-0.04
|
-0.49
|
0.41
|
1.23
|
0.49
|
1.09
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
1.11
|
3.26
|
1.24
|
|
|
|
|
|
|
EV/EBITDA
|
-16.77
|
-66.76
|
9.79
|
5.86
|
6.41
|
7.28
|
|
|
|
|
|
|
Close Price (₹)
|
12.55
|
14.95
|
52.10
|
202.10
|
67.85
|
179.00
|
|
|
|
|
|
|
High Price (₹)
|
24.25
|
66.90
|
243.40
|
252.50
|
292.00
|
486.90
|
|
|
|
|
|
|
Low Price (₹)
|
10.10
|
14.05
|
45.15
|
68.10
|
51.00
|
151.60
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
7.60
|
28.53
|
101.35
|
390.99
|
128.63
|
229.63
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
3.89
|
-17.12
|
4.99
|
3.00
|
2.85
|
2.94
|
|
|
|
|
|
|
Short term debt to equity ratio
|
4.28
|
0.48
|
1.81
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
0.10
|
0.10
|
0.24
|
0.65
|
5.52
|
6.84
|
|
|
|
|
|
|
Quick Ratio
|
0.06
|
0.07
|
0.07
|
0.15
|
3.25
|
4.49
|
|
|
|
|
|
|
Interest Coverage
|
-2.21
|
-2.81
|
0.61
|
2.49
|
2.09
|
4.01
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 | Mar-03 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.91
|
20.96
|
4.63
|
5.14
|
29.12
|
24.34
|
|
|
|
|
|
|
Asset Turnover
|
0.09
|
0.09
|
0.45
|
0.71
|
0.95
|
0.96
|
|
|
|
|
|
|
Receivable days
|
--
|
83.75
|
20.49
|
57.28
|
83.82
|
65.05
|
|
|
|
|
|
|
Inventory Days
|
--
|
219.24
|
93.89
|
80.74
|
63.27
|
50.06
|
|
|
|
|
|
|
Payable days
|
--
|
432.78
|
172.48
|
132.93
|
24.07
|
21.32
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-129.79
|
-58.11
|
5.09
|
123.01
|
93.79
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
